SCHEMBL6964494

SCHEMBL6964494

O=c1cc(O)oc(-c2ccccc2)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PRKDC P78527 2/20 0.49
SMN1; SMN2 Q16637 7/20 0.49
MAPT P10636 6/20 0.49
CYP19A1 P11511 6/20 0.49
FTO Q9C0B1 5/20 0.49
CYP1B1 Q16678 5/20 0.49
MEN1 O00255 5/20 0.49
CYP3A4 P08684 5/20 0.49
KMT2A Q03164 5/20 0.49
TP53 P04637 5/20 0.49
HPGD P15428 5/20 0.49
KDM4E B2RXH2 5/20 0.49
ALOX15 P16050 4/20 0.49
CYP1A2 P05177 4/20 0.49
ALDH1A1 P00352 4/20 0.49
HSD17B10 Q99714 4/20 0.49
PKM P14618 3/20 0.49
CYP1A1 P04798 3/20 0.49
ALOX12 P18054 2/20 0.49
AR P10275 2/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1344376 0.85 PRKDC (0.56) PRKDCSMN1; SMN2MAPTCYP19A1FTO
SCHEMBL1176530 0.77 ALDH1A1 (0.58) PRKDCSMN1; SMN2MAPTCYP19A1FTO
SCHEMBL11085896 0.76 NQO1 (0.54) PRKDCSMN1; SMN2MAPTCYP19A1CYP1B1
SCHEMBL3427191 0.76 PRKDC (0.49) PRKDCSMN1; SMN2MAPTCYP19A1FTO
SCHEMBL11084153 0.74 SLC9A1 (0.47) PRKDCSMN1; SMN2MAPTFTOCYP1B1
SCHEMBL9179291 0.73 PLA2G2A (0.49) PRKDCSMN1; SMN2CYP19A1CYP1B1MEN1
SCHEMBL9204834 0.73 PRKDC (0.46) PRKDCSMN1; SMN2MAPTCYP19A1CYP1B1
SCHEMBL6172775 0.72 SMN1; SMN2 (0.54) PRKDCSMN1; SMN2MAPTCYP19A1FTO
SCHEMBL14449832 0.72 PRKDC (0.45) PRKDCSMN1; SMN2MAPTCYP19A1FTO
SCHEMBL11085347 0.72 PRKDC (0.45) PRKDCSMN1; SMN2MAPTCYP19A1FTO

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0729465-B1 PYRONE DERIVATIVES AS PROTEASE INHIBITORS AND ANTIVIRAL AGENTS PARKE DAVIS & CO (US) 2003-01-22 EP disclosed